Although BRD7 was discovered in 1999, its role as a tumor suppressor was not well characterized until 2010, when several groups reported that BRD7 interacts with p53, a potent tumor suppressor that is frequently mutated in human cancers [83]. Here, BRD7 is linked to neoplasm.